| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |